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Galactooligosaccharides (GOS) are prebiotics that are being used to influence 
intestinal microbiota towards health promoting, beneficial bacteria like bifidobacteria.  
Natural sources of GOS are not found in suitable levels to achieve the desired health 
effects so economically viable commercial production methods are important.  Enzymatic 
conversion of lactose to GOS through transgalactosylation is a preferred method since the 
starting material is inexpensive and readily available.  Enzymes used in batch production 
are purified from fungal or bacterial sources or remain in whole cells cultured for GOS 
production.  Purified or unbound enzymes are single use whereas enzymes retained 
within whole cells can potentially be used for multiple cycles.  In the present study 
Bifidobacteria bifidum ATCC 700541 is investigated as an organism for GOS production.  
The strain was cultured using a previously successful medium for growing bifidobacteria 
and the β –galactosidase activity was measured and compared to levels in purified 
enzymes from A. niger and E. coli.  We found that when compared to purified enzyme 
activity levels the costs of a single batch reaction using whole cells is the same as using 
purified enzymes.  When the possibility for reusing the cells for multiple batches of GOS 
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The human gastrointestinal tract is a dynamic array of diverse micro-organisms 
consisting of both potentially harmful and potentially beneficial bacterial species. A 
major function of the colonic microbiota is to act as scavengers, harvesting the energy 
stored in dietary residue that passes through the stomach and small intestine undigested. 
Members of the genus Bifidobacterium, genus Lactobacilli and other beneficial bacteria 
provide health benefits to their host by outcompeting potentially harmful microbiota 
cohabitating the colon.  Bifidobacteria are the most abundant beneficial bacteria.  
Bifidobacteria utilize indigestible sugar molecules called oligosaccharides for growth and 
also ferment these sugars into vitamins and other nutrients which provide health benefits 
to the host.  Recent research uses diet to influence microbial populations of the gut 
towards the beneficial microbiota, thereby increasing host health.  Figure 1.1 is an 
overview of the major species found in the gut, their relative numbers, and potential 
health effects. 
One way to influence gut microbiota is through the use of probiotics and 
prebiotics.  Probiotics are live organisms added to foods, such as yogurt products like 
Activia
©
, and after they are ingested they remain in the gut and provide health benefit to 
the consumer.  Prebiotics, on the other hand, are nutritional elements which pass the 
stomach undigested thus allowing the indigenous bacteria of the gut to utilize them for 
growth and the host receives the benefits.  Oligosaccharides have been identified as 
prebiotics for the purpose of increasing microbial numbers of such beneficial bacteria.  
Oligosaccharides, such as fructo-oligosaccharides (FOS), galacto-oligosaccharides 
(GOS), and inulin are naturally occurring in foods such as bananas, tomatoes, soybeans, 
garlic, onions, and asparagus and also in human and bovine milk.  Human milk, in 
particular, is rich with GOS and comparison of nursing infants to infants fed formula 
indicates GOS is essential to increasing the abundance of indigenous Bifidobacteria in 
the large intestine increasing the health benefit to the host while minimizing potential 
side effects.  Natural sources of GOS are insufficient or inconvenient to extract for use as 
health enhancing additives. A way of producing synthetic GOS is necessary to meet 





Figure 1.1  Generalized Scheme and Health Effects of Predominant Human Fecal 
Bacteria (Isolauri et al. 2004). 
 
 
Current commercial production of synthetic GOS involves using a -
galactosidase enzyme to convert a high concentration lactose solution to a heterogeneous 
solution comprised of varying length GOS, galactose, and glucose.  The feed stream for 
the conversion is usually lactose whey concentrate, a by-product considered waste of the 
dairy industry.  Figure 1.2 illustrates an overview of a cheese making process and whey 
production.  -galactosidase enzymes used for production of GOS are typically isolated 
from yeasts, fungi, and other bacteria such as E. coli.  Most species of Bifidobacteria 
produce -galactosidase as well as -galactosidase. 
The main linkage structure present in GOS converted from lactose is -galn-(1-4)-
-glc although other β-glycosidic linkages have been found including -galn-(l-6)- -gal, 
-galn-(1-2)- -glc, -galn-(1-3)- -glc, -galn-(1-4)- -glc, -galn-(1-6)- -glc, -galn-(1-2)-
-gal and -galn-(1-3)- -gal.  GOS not derived from lactose also include α-glycosidic 
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linkages such as α -gal (1-6)2- α -glc and α -gal (1-6)2- α –gal.  While there is no direct 
evidence that -linked or -linked sugars provide different benefits it is believed that 
both linkage types within the GOS molecule provide health benefit to the host without the 






Figure 1.2  Overview Schematic of Cheese Processing with End Products as Cheese, 




The percent conversion of lactose to GOS depends on time, temperature, initial 
lactose concentration and, as recent work has shown, enzyme source.  Since reaction time 
is a key factor for maximum conversion of lactose to GOS, the use of extracted enzymes 
requires enzyme inactivation, usually by temperature denaturation, to end the reaction at 
the optimized time.  Denaturation renders the enzyme unusable so fresh enzyme must be 
used for each GOS conversion batch.  In order to create a more economical GOS 
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production process, promising work has been done using cells of a novel strain of 
Bifidobacteria bifidum.  Since the enzymes are contained within the cell structure, using 
cells allows for physical removal of the enzyme source from the reaction mixture without 
deactivating the enzyme and allowing recycle of the enzymes for multiple conversions. 
In order for the use of whole cells to be economical a strain should be grown on 
an inexpensive media using a readily available sugar as its carbohydrate source.  The 
culture must also reach a high cell density with desirable enzyme kinetics.  Bifidobacteria 
do not easily grow on a purely synthetic media.  Much effort has been put towards 
determining what growth factors exist and how they can be incorporated into a synthetic 
media.  So far, research has identified that human milk, bovine milk casein fractions and 
yeast extract contain growth enhancers but the mechanism of enhancement is not known.  
The biggest obstacle to determining the specifics to growth enhancement is that the 
growth patterns of each Bifidobacteria, including different strains within the same 
species, have drastically different results when grown under the same media conditions. 
The scope and focus of this work is to investigate B. bifidum ATCC 700541 as a 
potential organism for GOS production as an alternative to purified enzymes.  The 
organism must actively grow on a convenient, simple media and also produce significant 
quantities of the -galactosidase enzyme to be useful for the production process.  The -
galactosidase activity of the cells will also be evaluated as it has been shown that -
linked GOS may provide additional benefit as a prebiotic agent.  The kinetics of the 
investigated strain of B. bifidum are compared to the kinetics of purified -galactosidase 
from E. coli (Sigma Aldrich, MFCD00130623) and purified -galactosidase from 
Aspergillus niger (Deerland Enzymes).  The economics of culturing bacteria are 





2.1. PROBIOTICS AND PREBIOTICS 
Live Lactobacilli and Bifidobacteria cultures ingested in pill form or added to 
food products with the aim of increasing the intestinal numbers of beneficial bacteria are 
known as probiotics.  In 1989, probiotics were defined as live microbial feed supplements 
which beneficially affect the host by improving its intestinal microbial balance (Fuller 
1989).  In 2001, the World Health Organization further defined a probiotic as “a live 
micro-organism which when administered in adequate amounts confer a health benefit on 
the host” (www.who.int/entity/foodsafety Nov 2010; Leahy et al. 2005).  Establishing 
change in the gut microbiota through probiotics requires passing the bacteria through the 
stomach to the intestines in a viable form.  In order for the probiotic organism to become 
established in the intestinal tract, the cultures must remain viable during processing and 
storage, resist the acidic environment of the stomach fluids, compete with existing gut 
bacteria for nutrients and adhere to the intestinal wall (Fuller 1991; Isolauri et al. 2004).  
Probiotic treatment requires repeated ingestion for sustained benefit since often the 
organism washes out of the host when it is discontinued as part of the diet (Gibson and 
Roberfroid 1995).  To overcome the obstacles presented by probiotic therapy, researchers 
began looking at alternatives for influencing gut microbiota towards beneficial bacteria. 
The alternative to ingesting the desired organisms is to stimulate the indigenous 
populations.  Research shows that Bifidobacteria and Lactobacilli are capable of utilizing 
food elements for growth that many gut bacteria cannot digest.  A nondigestible food 
ingredient that beneficially affects the host by selectively stimulating the growth or 
metabolic activity of a single or limited number of bacteria imposing a health benefit 
upon the host is the definition of a prebiotic (Gibson and Roberfroid 1995; Leahy et al. 
2005).  Based on this definition the current criteria for classifying a food component as a 
prebiotic are it must: a) be able to pass through the upper gut undigested b) provide 
selective fermentation by a single or limited number of beneficial bacteria in the colon c) 
provoke the colonic microbiota towards a healthier composition and d) generate effects 
that are beneficial to the host health (Fooks and Gibson 2002).  Oligosaccharides are non-
digestible carbohydrates that possess these characteristics. 
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In 1999 the value of functional food additives in the U.S. was estimated at $163 
million and was expected to increase by 7% annually reaching $322 million by 2009 
(Reisch 2001).  With public awareness through major marketing campaigns of 
commercial products such as yogurts and other fermented dairy products the market has 
reached $16 billion and is expected to continue to increase at a rate of 12.6% a year the 
next 5 years reaching $32.6 billion (Markets and Markets, 2009).  Oligosaccharides have 
emerged worldwide as the focus of a new health movement and in 2001 the U.S. Food 
and Drug Administration (FDA) approved Galacto-oligosaccharides (GOS) as a dietary 
ingredient (FDA, 2001).  Oligosaccharides are obtained by extraction from natural 
sources or synthesized through glycosylation reactions, enzymatic hydrolysis of 
polysaccharides, or transgalactosylation reactions (e.g. GOS and FOS) (Espinosa-Martos 
and Ruperez 2006; Borman 2007; Hsu et al. 2007).  GOS are proving to be promising 
food additives in that they are stable in high temperature acidic environments and can be 
added as sugar substitutes in a variety of foods including infant formulae, dairy products, 
sauces, soups, cereals, beverages, snack bars, ice cream, breads, and animal feeds 
(Macfarlane et al. 2008; Manning and Gibson 2004).  Also, GOS has a convenient 
starting material in cheese whey.  Whey contains lactose and is abundantly available as a 
byproduct of cheese making.  After concentration, the lactose in the whey is converted to 
GOS through enzymatic transgalactosylation.  Using whey to produce GOS adds value 
and eliminates a costly waste stream (Pruksasri 2007). 
 
2.2. GALACTO-OLIGOSACCHARIDES (GOS) 
Oligosaccharides are indigestible, multi-moiety carbohydrate molecules that pass 
undigested through the stomach and small intestines into the large intestines.  GOS are 
oligosaccharides which contain two to five galactose molecules and a single glucose 
molecule linked through glycosidic bonds.  GOS possess a molecular structure 
generalized as (Galactose)n – Glucose (Sako et al. 1999).  GOS are found naturally in 
bananas, tomatoes, soybeans, garlic, onions, and asparagus and also human milk.  The 
FDA has granted GOS the generally regarded as safe (GRAS) status allowing 
commercial uses for human consumption. GOS are used as additives to infant formula 
and as food sweeteners with a reported caloric value of 1.75 kcal/g compared to 4.2 
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kcal/g caloric value of sucrose (table sugar) (Macfarlane et al. 2008).  The true value of 
GOS comes from the health benefits incurred by the host when they are consumed. 
2.2.1. Health Benefits of GOS.  Research indicates consuming 4-8 g/day of GOS 
can provide the desired health benefits.  A gut with an already healthy microbial balance 
will likely see little or no benefit and can possibly have the ill effect of increasing 
discomfort, in particular gas and bloating (Manning and Gibson 2004).  However for 
individuals who gain from GOS consumption the benefits experienced are directly related 
to the effect GOS has on the microbial composition in the intestine.  Intestinal bacteria 
have nonspecific metabolic pathways and utilize an array of sugars as carbohydrate 
source for growth; however, amongst all the intestinal organisms Bifidobacteria grow at a 
faster rate on GOS and convert GOS to cell mass to a greater extent (Macfarlane et al. 
2008; Rycroft et al. 2001).  An increased presence of Bifidobacteria has an antagonistic 
effect on the pathogenic organisms in the gut by metabolic suppression and reduced toxin 
release (Macfarlane et al. 2008).  Consuming GOS is a treatment for diarrhea related to 
food poisoning and traveler’s sickness since it promotes the growth of indigenous healthy 
bacteria and in so doing makes it more difficult for pathogens to establish and survive.  
Bifidobacteria prevent colonization of new pathogens by using available nutrients 
keeping harmful bacteria from being able to establish a significant presence in the gut 
(Isolauri et al. 2004; Leahy et al. 2005). 
Intestinal microbiota is established during the birth process.  Studies on infants 
who are fed mother’s milk vs. those fed infant formulae show that in those which are fed 
mother’s milk Bifidobacteria dominate the bacterial numbers accounting for up to 95% of 
the bacterial population where those which are fed formula have bacterial profiles more 
similar to an adult (Macfarlane et al. 2008).  Studies also show that the Bifidobacteria 
present in the breast fed infants play an important role in establishing the immune system, 
protects the infant from development of allergies, and prevents bouts of acute and chronic 
diarrhea.  Infant formula is fortified with GOS in atempt to promote these same health 
effects in infants which are not breast-fed (Isolauri et al. 2004; Leahy et al. 2005). 
In adults some benefits attributed to Bifidobacteria are stimulating immunological 
factors, lessening bloating caused by gas, improving digestion, aiding in absorption of 
essential nutrients, increasing calcium balance, producing vitamins and digestive 
  
8 
enzymes and releasing short chain fatty acids which are used for energy (Gibson and 
Roberfroid 1995; Leahy et al. 2005).  Bifidobacteria inhibit growth of pathogenic 
bacteria by releasing acidic metabolites (e.g. lactate and acetate) that lower the pH of the 
gut making a harsher environment for survival. Some metabolites act as antimicrobial 
agents directly.  Amines and ammonia released when proteins are digested are protonated 
by the acidic metabolites causing blood levels of toxic ammonia to decrease (Gibson and 
Roberfroid 1995).  Consuming GOS helps promote Bifidobacteria growth restoring the 
intestinal microbial balance after the administration of antibiotics which, in elderly 
patients especially, can wipe out the indigenous Bifidobacteria and Lactobacilli in 
addition to the bacteria actually causing the infection.  GOS are also used to correct 
bowel inconsistencies (Gibson and Roberfroid 1995; Fooks and Gibson 2002).  Research 
is being conducted to define the role that Bifidobacteria play in the prevention of colon 
cancer, irritable bowel syndrome and other colon related diseases.  The extent to which 
GOS consumption can benefit the consumer is an area of research that is receiving a great 
amount of attention and it will be likely many years before it is fully understood. 
2.2.2. Methods  of  GOS  Production.  In an adult diet or for infants not feeding 
on mother’s milk it is difficult to attain through natural food sources the recommended 4-
8 grams/day of GOS needed for the desired health benefits.  Commercially produced 
GOS are added as low calorie sweeteners to consumer goods such as infant formulas, 
dairy products, sauces, soups, cereals, beverages, snack bars, ice cream, and breads in 
order to supplement natural sources to reach the recommended daily dose (Macfarlane et 
al. 2008; Manning and Gibson 2004).  Methods of production include synthesis reactions 
(Borman 2007), extraction from natural sources such as soybeans (Espinosa-Martos and 
Ruperez 2006) and enzymatic transgalactosylation reactions to convert the high 
concentration lactose solution into a mixture of GOS and other sugars.  Enzymatic 
conversion reactions are carried out in numerous ways and are the most utilized method 
for GOS production (Sako et al. 1999).  Lactose from cheese processing is the preferred 
and most convenient starting material.  Figure 2.1 shows the overall production scheme 










Enzymatic conversion can be applied as any of the following: a) Batch 
production, illustrated in Figure 2.2, in which enzymes purified from either a microbial or 
fungal source are added to a concentrated lactose solution, incubated, and then heated to 
terminate the conversion by denaturing the enzymes (Onishi and Tanaka 1995; Splechtna 
et al. 2006; Hsu et al. 2007) b) Biotransformation production, also illustrated in Figure 
2.2, using whole cells containing the useful enzymes in a batch reactor.  As with purified 
enzymes the whole cells are added to the lactose solution and incubated.  After 
incubation the solution is not heated to denature the enzymes.  Instead, the cells are 
removed from the solution by either filtration or centrifugation so they can be reused 








Figure 2.2  GOS Production Using a Batch Reaction with Whole Organisms or Purified 
Enzymes to Convert Lactose. 
 
 
c) Continuous fed-batch reaction is shown in Figure 2.3.  Enzymes or whole cells are 
added to a high concentration lactose solution and after incubation the mixture is 
circulated through a tangential flow membrane.  The enzymes or cells are retained on the 
retentate side of the membrane and the sugar solution is removed as permeate.  To drive 
the reaction towards continuous GOS production, a high concentration lactose solution is 
fed to the reactor at the same rate that permeate is leaving the system keeping the volume 
in the reactor constant (Chockchaisawasdee 2005) and d) Immobilization where enzymes 
or cells are entrapped in porous beads and packed in a column as shown in Figure 2.4.  
Concentrated lactose solution is passed over the column where the conversion reactions 
take place and the outlet stream is collected for further processing (Dey-Chyi et al. 1998; 






















In order to have an efficient process it is important to be able to convert the most 
amount of lactose at the least amount of cost.  If whole cells can be grown so they contain 
a sufficient amount of enzyme activity then they provide opportunity for cost 
effectiveness based on potential for reuse.  Slow diffusion kinetics and problems with 
fouling, plugging and pressure drop limit the potential for immobilization to be cost 
effective.  Using pure enzyme is effective for constant dosing for conversion but is costly 
due to single use. 
2.2.3.  GOS  Reaction  Kinetics  Using  Lactose.   GOS synthesis from lactose is 
characterized by an initially rapid decrease in lactose concentration and is accompanied 
by the formation of glucose and galactose.  The final reaction product is a mixture of 
monosacharides (glucose and galactose), disaccharides (lactose and allolactose), 
trisaccharides and tetrasaccharides (GOS).  Figure 2.5 is a chromatographic 






Figure 2.5  Separation by Capillary Electrophoresis of Individual GOS Products During 
Lactose Conversion Catalyzed by β-Galactosidase. (1) glucose (2) galactose (3) lactose 






As the conversion of lactose progresses towards 100% conversion the 
concentrations of glucose and galactose continue to increase and the concentration of 
GOS decreases.  This reaction scheme suggests that in transgalactosylation GOS are 
formed as intermediates and are subject to hydrolysis thus serving as substrates as lactose 
becomes depleted.  Figure 2.6 shows the reaction kinetics of lactose conversion by β-
galactosidase from Bifidobacterial longum BCRC 15708 carried out at 45 °C and pH 6.8 
with an initial lactose concentration of 40%.  GOS concentrations increase steadily until 
lactose conversion reaches about 50% then there is a sharp drop in GOS concentration 
and if allowed to continue, the GOS would completely hydrolyze into galactose and 






Figure 2.6  Lactose Conversion by β-Galactosidase from Bifidobacterial longum BCRC 
15708.  Carried Out at 45 °C and pH 6.8 with an Initial Lactose Concentration of 40% 





Much work has been done to find conditions which maximize GOS production.  
Research has shown that enzyme source, temperature, pH, hydrolysis product 
concentrations and most importantly initial lactose concentration dictate GOS 
concentrations during processing.  Enzyme source will determine what pH and 
temperature are optimal for conversion.  For example, in a study using β-galactosidase 
from E. coli, the optimal pH was between 7 and 7.5 (Huber et al. 1976) whereas in a 
study using β-galactosidase from Bifidobacterium longum the optimal pH was 6.8 (Hsu et 
al. 2007).  Most conversion reactions are run at 40 - 45 °C but some enzymes purified 
from thermophilic organisms are capable of operating at higher temperatures.  In general 
both glucose and galactose have an inhibitory effect and decrease total GOS formation 
(Hsu et al. 2007; Chockchaisawasdee et al. 2005; Onishi et al. 1995).  In a study using β-
galactosidase from Kluyveromyces lactis it was demonstrated that the conversion of 
lactose to GOS is independent of enzyme concentration.  The results of this study, as 
presented in Figure 2.7 and Table 2.1, show that increasing enzyme concentration causes 
the reaction to progress to the end point faster but did not impact the overall amount of 






Figure 2.7  Time Course of GOS Synthesis From 340 mg/mL Lactose Using Differing 
Concentrations of Enzyme ((a), 2.9 U/mL, (b), 5.8 U/mL, (c), 8.7 U/mL) in a Batch 
Reactor at 40 °C, pH 7 (x, lactose; Δ, glucose; □, galactose; ●, GOS) 




No matter the enzyme source it is evident that at lower lactose concentrations the 
hydrolysis reaction is the dominant reaction.  Initial lactose determinations made using B. 
longum, K. lactis, and B. bifidum all demonstrate that initial concentrations of lactose 
between 40% and 50% are necessary to engage the transgalactosylation reaction of the 
enzymes in order to produce GOS.  The dramatic effect that changes in initial lactose 
concentration has on GOS production in contrast to fluctuations in pH or temperature are 





Table 2.1  Observed GOS Concentration in a Batch Reactor Over 4 h at 40 °C at pH 7 
(Chockchaisawasdee et al. 2005). 











2.9 U/mL 53 68 88 96 
5.8 U/mL 49 64 85 99 
8.7 U/mL 45 62 81 96 








Figure 2.8  Effects of Temperature (pH 6.8, 40% lactose), pH (45 °C, 40% lactose) and 
Initial Lactose Concentration (pH 6.8, 45 °C) on GOS Production Catalyzed by β-
Galactosidase from B. longum. (Hsu et al. 2007). 
 
 
2.3. ENZYME ACTION 
In the early 1950’s oligosaccharides were discovered during lactose hydrolysis 
reaction studies using lactase.  Figure 2.9 shows a lactose hydrolysis reaction by β-








Figure 2.9  Lactose Hydrolysis Reaction by β-Galactosidase. 
 
 
In commercial production, galactosidase enzymes are the functional enzymes in 
lactose conversion to GOS.  In 1953 John Pazur proposed a two step process as the 
mechanism for the enzymatic synthesis of GOS by β-galactosidase transgalactosylation.  
The first step in Pazur’s proposed two step process is the formation of a galactose-
enzyme complex and the liberation of glucose.  The second step in his process is the 
transfer of the galactose molecule from the galactose-enzyme complex to a cosubstrate in 
the system to form the GOS molecule.  Figure 2.10 illustrates the mechanism proposed 
by Pazur.  In his system, if the cosubstrate is glucose then complex I, allolactose, is 
formed.  If the cosubstrate is galactose then complex II is formed.  If the cosubstrate is 
lactose or allolactose then either complex III or IV, GOS, are formed.  Complex III 
consists of glucose β(1-6) galactose β(1-4) galactose and complex IV consists of glucose 
β(1-4) galactose β(1-4) galactose (Pazur 1954).  This mechanism can be extended to 








Figure 2.10  GOS Formation Mechanism as Proposed by Pazur (Pazur 1954). 
 
 
In 1976 R.E. Huber et al. further characterized the reaction mechanisms involved 
in GOS synthesis.  They showed that β-galactosidase has two transgalactosylase 
functions and a hydrolysis function.  The transgalactosylase functions are described as 
“indirect” transgalactosylase activity and “direct” transgalactosylase activity.  Indirect 
transgalactosylase activity happens as Pazur describes where lactose is bound by the 
enzyme, glucose is released, and the galactose releases to an acceptor molecule.  Direct 
transgalactosylase activity involves the binding of the lactose by the enzyme, the 
cleavage of the β-(1-6) bond and the formation of a β-(1-4) bond with the same glucose 
molecule forming allolactose (Huber et al. 1976).  Figure 2.11 shows the linkage 








Figure 2.11  Lactose and Allolactose Molecules. 
 
 
Juers et al. further explains the action of β-galactosidase.  They suggest that β-
galactosidase has two binding positions, shallow and deep binding.  β-galactosidase 
hydrolyzes the substrate in a double displacement reaction with protonation of the leaving 
group (glucose) being a rate limiting step.  During the formation of the galactose-enzyme 
intermediate complex the substrate first binds in the shallow binding position then moves 
into the deep binding position of the active site and the glycosidic bond is cleaved.  The 
second step of the reaction is an acceptor molecule performs a nucleophilic attack on the 
bound galactose forming the reaction products.  In hydrolysis the acceptor molecule is 
water.  In transgalactosylation the acceptor molecule is either glucose, forming 
allolactose, or a di- or tri- saccharide forming GOS.  Both free glucose and galactose 
effect the GOS formation reaction by binding the enzyme and competitively inhibiting 
the initial hydrolysis reaction (Juers et al. 2001).  The extent to which the reaction is 
inhibited depends on the enzyme source and other reaction conditions (Hsu et al. 2007; 
Tzortis et al. 2005). 
The thermodynamics of the catalysis favor hydrolysis; however, the available 
alcohol groups on the carbohydrates in solution, which allow them to act as acceptor 
molecules, cause GOS yield and compositions to change dramatically with reaction time.  
Figure 2.12 graphs the formation and degradation of individual GOS products over time 
from a lactose conversion reaction using β-galactosidase derived from Lactobacillus 
reuteri.  In addition to time, the composition of GOS is also highly dependent on the 
source of β-galactosidase. Comparing GOS products using β-galactosidase from 
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Lactobacillus reuteri, Pyrococcus and Sofolobus solfataricus shows the composition 
variation between the enzyme sources and also the variation of linkages within the GOS 
molecules.  Typically the linkages between the monomers are β-(1-4) glycosidic bonds; 
however, Table 2.2 compares the variety of glycosidic linkages in GOS in research 





Figure 2.12  Formation and Degradation of Individual GOS During Lactose Conversion 
by β-galactosidase from L.  reuteri (Initial Lactose Concentration , 205g/L).  (●) total 






Table 2.2  Observed Glycosidic Linkages and GOS Compositions (Splechtna et al. 2006; 
Petzelbauer 2001; USFDA 2001). 











gal (1-3) glc gal (1-3) glc 
gal (1-6) glc gal (1-3) glc 
gal (1-6) gal gal (1-6) glc 
gal (1-6) glc gal (1-6) glc 
gal (1-3) glc 
gal (1-4) gal 
gal (1-3) gal 
Trisaccharides 
gal (1-3) gal 
(1-4) glc 
gal (1-3) gal 
(1-4) glc 
gal (1-3) gal 
(1-4) glc 
gal (1-4) gal 
(1-4) glc 
gal (1-6) gal 
(1-4) glc 
gal (1-6) gal 
(1-4) glc 
gal (1-6) gal 
(1-4) glc 
gal (1-6) gal 
(1-4) glc 





gal (1-3) gal 
(1-3) gal (1-4) 
glc 
NA NA 
gal [(1-6) gal 
(1-4)]n gal 
(1-4) glc 
*All linkages are β-glycosidic bonds.  Gal (1-6) Glc is allolactose. 
 
 
While the health benefits directly related to GOS with α-galactosidic bonds have 
not been fully investigated, an organism with α-galactosidase activity is able to utilize α-
linked sugars such as raffinose and stachyose which are naturally occurring in soybeans.  
The known mechanism of α-galactosidase is primarily in the hydrolysis of α-linked 
oligosaccharides.  However, in their investigation of α-galactosidase hydrolysis kinetics, 
Konstantin et al. observed transgalactosylation activity using melibiose, an α-linked 
disaccharide of glucose and galactose, resulting in the formation of GOS (Shabalin et al. 
2002).  Research efforts are being directed towards finding α-galactosidases capable of 
synthesizing GOS for the prebiotic production.  Studies using Bifidobacteria 
adolescentis, Bifidobacteria breve, and Bifidobacteria bifidum are yielding promising 
results (Goulas et al. 2009a).  
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The kinetic properties of both enzymes are dependent upon pH and temperature.  
As described earlier, depending on the source of the enzyme the optimum conditions and 
final product structure and composition vary.  Huber et al. confirm the optimal pH for β-
galactosidase to be between 6.5 and 7.0 (Huber et al. 1976).  Jurado et al. agree and show 
ideal temperatures range from 40°C to 50°C.  They also establish a relationship between 




GOS and other prebiotics modify intestinal health by influencing beneficial, 
health promoting bacteria.  The primary targets of prebiotics are members of the 
Bifidobacterium genus and Lactobacillus genus (Macfarlane et al. 2008).  Studies have 
shown bifidobacteria to be the dominant players in the health and development of the 
lower digestive tract microbiota in infants (Niittynen et al. 2007).  Bifidobacteria have 
also been shown to be key in the health of the elderly with particular attention paid to 
intestinal microbiota recovery after the administration of antibiotics (Hamilton-Miller 
2004; Macfarlane et al. 2008).  Since bifidobacteria play such an important role in the 
health of the human gastrointestinal tract and have other health related benefits much 
effort is being made to characterize and understand what influences their growth. 
Until recently, Bifidobacterium were known as Lactobacillus bifidus since they 
demonstrated many of the same properties as members of the Lactobacillus genus.  
However, bifidobacteria were found to involve the use of the enzyme fructose-6-
phosphate phosphoketolase in their carbohydrate metabolic pathway which is not used in 
other species of Lactobacillus.  In addition closer study of cell morphology, DNA and 
nutritional requirements for growth revealed Bifidobacterium as its own genus.  Members 
of Bifidobacterium genus are gram positive, anaerobic bacteria.  Bifiobacterium are a 
diverse group of species which are not nutritionally homogeneous.  The nutritional 
requirements and aerotolerance of each species are strain dependent.  One commonality 
amongst species of Bifidobacterium is they are not readily cultured on a purely synthetic 
media but require a complex nutritional component, such as casein or yeast extract, for 
culturing (Poupard et al. 1973; Poch and Bezkorovainy 1988).  One species of 
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bifidobacteria that has been used as a probiotic and has received significant attention for 
prebiotic targeting is Bifidobacteria bifidum.  The interest in these strains is directly 
linked to their β-galactosidase and α-galactosidase activities and how they respond to 
GOS and other prebiotics in vitro (Kneifel, and Kulbe 2000). 
2.4.1. Bifidobacteria  Utilization  of  GOS.  Bifidobacteria have been selected as 
targets for prebiotic gut manipulation due to the potential health benefits that come from 
having increased numbers in the gut.  Researchers have spent time examining how 
different prebiotic carbohydrates affect Bifidobacteria in vitro in order to gain 
understanding of the behavior in the gut.  In the digestive tract a majority of simple 
carbohydrates that promote Bifidobacteria enumeration are absorbed in the stomach and 
small intestines.  Selecting GOS as a suitable prebiotic is the result of research showing 
that Bifidobacteria readily utilize GOS and other oligosaccharides whereas 
Enterobacteria and other harmful organisms do not.  Hopkins et al. (1993,1985) and 
Minami et al. (1998), show evidence that Streptococcus, Lactobacillus, and Escherichia 
readily utilize reducing sugars (glucose, fructose, maltose and lactose) but poorly utilize 
non-reducing sugars (GOS, FOS, etc) and Bifidobacteria generally utilize mono to 
tetrasaccharides, particularly those containing galactose, without requiring an adaptation 
period.  They also conclude that as a general rule sugars containing galactose, glucose 
and fructose are fully utilized by Bifidobacteria (Minami et al. 1983, 1985; Hopkins et al. 
1998).  Rabiu et al. provide evidence that species show preference for GOS synthesized 
using cells of the same species.  Table 2.3 lists the growth rates of selected gut bacteria 
on synthesized GOS (Rabiu et al. 2001).  Evidence of improved growth of Bifidobacteria 
species on GOS made using β-galactosidase from the same organism adds to the rationale 





Table 2.3  Growth Rates of Selected Gut Bacteria on GOS. 1) Control – Oligomate 2) B. 
bifidum BB-12 oligosacharide 3) B. infantis DSM-20088 oligosaccharide 4) B. 
pseudolongum DSM-20099 oligosaccharide 5)  B. adolescentis ANB-7 oligosaccharide 




2.4.2. Carbohydrate Source for Culturing and β-Galactosidase Production. In 
the gut Bifidobacteria have been shown to have a preference for oligosaccharides while 
other less beneficial bacteria cannot process these sugars.  Since the hydrolysis from the 
enzymes in the Bifidobacteria is desired for GOS production it is convenient to culture 
these bacteria.  A media that will support the growth of the Bifidobacteria and allow them 
to produce the desired enzyme activity level is necessary.  Bifidobacteria can grow on a 
variety of carbohydrate substrates; preference for a particular substrate is strain 
dependent (Hopkins et al. 1998; Mlobeli 1998).  Glucose lends itself as a simple 
carbohydrate that allows high cell yields for most strains of Bifidobacteria however 
glucose does not induce the expression of the α – galactosidase and β – galactosidase 
enzymes which are needed for GOS production or utilization in the gut.  Studies showed 
that sucrose and fructose are carbohydrates that promote high cell yields but also do not 
initiate production of the desired enzymes.  Galactose, lactose and arabinose each 
produced some measure of enzyme activity.  For Bifidobacterium bifidum, culture media 
containing lactose yields the highest growth rate with the highest specific enzyme activity 
(Astapovich and Ryabaya 2006).  Figure 2.13 is a graph of the β – galactosidase and cell 
growth of two strains of B. bifidum cultured on media containing various carbohydrates 








Figure 2.13  β–Galactosidase Activity (Dark Columns, U/ml) and Growth (Non Shaded 
Columns, mg/ml) of Bifidobacteria on Media with Various Carbon Sources. 1) Sucrose 
2) Lactose 3) Galactose 4) Glucose 5) Fructose 6) Maltose 7) Arabinose, 8) Cellobiose 
(Astapovich and Ryabaya 2006). 
 
 
Among the tested carbon sources that demonstrate production of β – galactosidase 
during cell culturing, lactose is the highest yielding sugar.  Figure 2.14 is a graph 
demonstrating the differences between lactose, glucose and galactose as carbohydrate 
sources as measured by cell growth and enzyme activity.  As can be seen in the graph the 
three sugars perform comparatively in terms of cell growth but lactose yields the highest 
enzyme activity (Hsu et al. 2005).  Since Bifidobacteria can grow on a lactose substrate, 
whey provides a convenient feed stream for culturing species, such as Bifidobacterium 








Figure 2.14  Effect of Carbon Source on Growth and β – Galactosidase Production (Hsu 
et al. 2005). 
 
 
2.4.3. Nitrogen  Source  for Culturing and  β-Galactosidase Production.  With 
a vast variety of species and differences between strains even within the same species of 
Bifidobacteria specific growth requirements for each has not been thoroughly 
investigated; however, much work has been done to find media that supports growth for 
all types.  Early investigations focused on developing a defined media capable of 
selectively culturing Bifidobacteria species.  First attempts at developing a synthetic 
medium included a carbohydrate, usually glucose or lactose or both, an assortment of 
vitamins, salts, amino acids and a nitrogen source generally called “bifid factors”.  Based 
on the “bifid factor” chosen different levels of growth activity were observed.  Initial 
media contained peptone which was later substituted by cow’s milk and then later human 
milk (Bezkorovainy and Miller-Catchpole 1989).  Modern media are comprised of 
combinations of tryptone, peptone, meat extract, yeast extract, ammonia salts, potassium 





The observation of increased activity with the addition of cow and human milk to 
the culture media led to further characterization of the growth promoting factors in the 
milk as well as investigation into other growth promoting agents.  Closer study of both 
types of milk revealed that there is a complex mix of protein and non-protein growth 
factors (Petschow and Talbott 1991).  When separated into casein and whey there is a 
significantly greater amount of growth activity associated with casein fractions than whey 
fractions for both human and cow milk (Petschow and Talbott 1990).  Other growth 
promoters were studied as well including yeast extract, gelatin, tryptone, peptone, hog 
gastric mucin, bovine serum albumin digest and beef extract (Poch and Bezkorovainy 
1988, 1991, Hsu et al. 2005).  Research indicates that for strains of Bifidobacteria 
bifidum employing yeast extract as the nitrogen growth-promoting source yields the 
greatest level of activity (Poch  and Bezkorovainy 1988).  When yeast extract is used in 
conjunction with casamino acids or ascorbic acid in a whey stream, culture cell mass is 
almost 100-fold greater than with yeast extract and whey alone and is comparable to 
MRS medium (Difco, Detroit MI, USA) which is one of a few complex prepared media 
used for culture maintenance (Corre et al. 1992). 
While the nitrogen source has a significant impact on the growth kinetics of the 
organisms it also appears to impact the β – galactosidase synthesis by the cells.  Figure 
2.15 shows the effect of nitrogen source on growth and β – galactosidase activity using B. 
longum.  The growth achieved by each of the nitrogen sources is comparable however 
yeast extract as the nitrogen source generates the greatest level of β – galactosidase 
activity.  Table 2.4 shows the effect of yeast extract concentration on growth and β – 








Figure 2.15  Effect of Nitrogen Source on the Growth and β–Galactosidase Production by 
B. longum CCRC 15708. Medium Contained 4% lactose, 0.3% K2HPO4, 0.1% KH2PO4, 
0.05% MgSO4d 7H2O, 0.03% l-Cysteine and Various Nitrogen Sources. Determinations 




Table 2.4  Effect of Yeast Extract Concentration on the Growth and β – Galactosidase 
Production by B. longum CCRC 15708.  Fermentation Was Conducted in a Medium 
Containing 4% Lactose, 0.3% K2HPO4, 0.1% KH2PO4, 0.05% MgSO4d 7H2O, 0.03% 







2.4.4. Temperature and pH Effect on Growth and β-Galactosidase Production. 
Temperature and pH are important environmental factors to optimize when culturing any 
micro-organism.  Some organisms are tolerant of a wide range of both temperature and 
pH while other organisms require a more controlled environment in order to grow.  
Bifidobacteria are organisms which will grow in a range of pHs and at various 
temperatures.  Hsu, et al. use B. longum to demonstrate the versatility of the 
Bifidobacteria species over a range of pHs and temperatures.  Their work also shows the 
effect that changes in initial media pH and culture temperatures has on β – galactosidase 
activity.  Figure 2.16 shows growth and β – galactosidase of B. longum cultures with 
varying initial pHs and Figure 2.17 shows growth and β – galactosidase of B. longum 






Figure 2.16  Effect of Initial pH on the Growth and β–Galactosidase Production by B. 








Figure 2.17  Effect of Temperature on the Growth and β–Galactosidase Production by B. 
longum.  Medium With an Initial pH 6.5 for 12-h Cultivation (Hsu et al. 2005). 
 
 
As is demonstrated there is not a single factor that determines growth and β – 
galactosidase activity of a Bifidobacteria culture.  Even within the same species the 
enzyme and growth kinetics differ from strain to strain so that carbohydrate source, 
nitrogen source with growth factors, pH and temperature should all be investigated in 
order to optimize cell growth and β – galactosidase production. 
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3. MATERIALS AND METHODS 
3.1. REAGENTS AND CHEMICALS 
2-Nitrophenyl β–D-galactopyranoside (ONPG), 2-nitrophenyl (ONP), 4-
nitrophenyl α-D-galactopyranoside (PNPG), and 4-nitrophenyl (PNP) were purchased 
from Sigma (St. Louis, MO).  β –Galactosidase was purchased from Sigma (St. Louis, 
MO).  α-Galactosidase was purchased from Deerland  Enzymes (Kennesaw, GA).  
Bifidobacteria bifidum NCIMB41171 was provided by Milk Specialties Global 
(Carpentersville, IL).  Bifidobacteria bifidum 700541 was purchased from American 
Type Culture Company (ATCC, Manassas, VA).  Difco
TM
 dehydrated media components 
were purchased from Becton, Dickinson and Company (BD Diagnostics, Franklin Lakes, 
NJ).  All other chemicals were purchased from Sigma (St. Louis, MO) or Fisher 
Scientific (Fair Lawn, NJ). 
 
3.2. DETERMINATION OF ENZYME ACTIVITY 
Reagent Preparation 
Stock solution of 100mM sodium phosphate buffer pH 6.8 (phosphate buffer) was 
prepared by dissolving the following in deionized (DI) water to make one liter.  The 
solution was filtered through a 0.2μm filter to remove dust and microbial contaminants.  
The resulting buffer is pH 6.8±0.2 
 
8.725 grams Na2HPO4●2H2O (MW 177.99 grams/mole) 
7.038 grams NaH2PO4●H2O (MW 137.99 grams/mole) 
 
Stock solution of 120mM sodium tetraborate stop reagent was prepared by 
dissolving 45.76 grams Na2B4O7●10H2O (MW 381.37 grams/mole) in one liter DI water 
then filtering the solution through a 0.2μm filter to remove dust and microbial 




3.2.1.   β  –  Galactosidase  Endpoint  Assay.   A  colorimetric  assay  is  used  to 
determine the enzymatic rate which β – Galactosidase cleaves the glycosidic bond of 
ONPG leaving free galactose and ONP.  In dilute concentrations, ONP is yellow in color 
and is detected by a spectrophotometer at 415nm (A415).  An increase in color intensity 
indicates hydrolysis.  The assay is carried out in 100mM sodium phosphate buffer pH 6.8 
at 40°C and stopped using 120mM sodium tetraborate solution. 
A. Standard Curve Preparation 
1. Standard solution of 10mM ONP was prepared using volumetric glassware by 
dissolving 139 milligrams of ONP (MW 139.1 grams/mole) in enough 
phosphate buffer to make 100 milliliters (mL).  
2. Standard solution of 1mM ONP was prepared by adding five mL of 10mM 
ONP to 45mL phosphate buffer.  
3. Standards for measurement were prepared by serial dilution of 1mM ONP 
standard in phosphate buffer to 1.35mL of the desired concentration according 
to Table 3.1. Each standard was prepared in triplicate.  
4. To mimic assay conditions, 0.15 mL phosphate buffer and 3 mL sodium 
tetraborate stop reagent were added to each standard.  The zero standard was 
used to blank the spectrophotometer and the absorbance of each standard was 
measured at 415nm using 1cm quartz cuvettes.  Figure 3.1 shows the standard 
curve with trend line analysis for ONP.  Raw data is given in Appendix A, 
Table A.1. 
The data was analyzed using ANOVA statistics and linear regression.  Statistical 
results are presented in Table 3.2 and Appendix B.  A P-value of <0.0001 indicates that 
the linear model for ONP concentration is significant.  The standard error can be used as 





Table 3.1  Serial Dilutions of ONP Standard Solutions for Standard Curve. 
[ONP] mM 




1 1.350 0 
0.9 1.215 0.135 
0.8 1.080 0.270 
0.7 0.945 0.405 
0.6 0.810 0.540 
0.5 0.675 0.675 
0.4 0.540 0.810 
0.3 0.405 0.945 
0.2 0.270 1.080 
0.1 0.135 1.215 


















Squares Mean Squares F-Value P-value 
Model 1 18.95929753 18.95929753 157408.5 <0.0001 
Residual 29 0.003492948 0.000120446 





Error Lower 95% Upper 95% 
Absorbance 415 1.281209437 0.003229283 1.274604812 1.287814062 
 
Regression Statistics 
Multiple R 0.999907896 
R Square 0.9998158 
Standard Error 0.010974812 
 
 
The extinction coefficient ( ) for ONP was calculated from the standard curve 
regression using Equation (1) where A415 is the absorbance measurement,  is the slope of 
the linear regression divided by dilution factor (ONP volume (mL)/total assay volume 
(mL)), and l is the path length (1cm).  The experimentally determined value of the 




.  The published literature value of the 




 lies outside the 95% confidence interval.  
The experimentally determined coefficient was used for the rate calculations. 
 
A415 =  [ONP] l (1) 
 
B. Enzyme Activity Determination 
1. Stock substrate solution of 10mM ONPG was prepared by dissolving 301.3 
milligrams of ONPG (MW 301.3 grams/mole) in 100mL of phosphate buffer.  
Buffer was stored cold in a light protective container.  
2. Cell samples were prepared at 1mg/mL dry cell weight in phosphate buffer.  




3. 1.35 mL of 10mM ONPG was dispensed into clean glass tubes and 
equilibrated to 40°C in a circulating water bath. 
4. 0.15 mL of 1 mg/mL cell sample was dispensed into the glass tubes to 
initiate the reaction.  The reaction was carried out at 40°C for 10 – 20 
minutes. 
5. After the appropriate amount of time had elapsed, 3 mL of sodium 
tetraborate was dispensed into each tube.  The tubes were removed from the 
water bath and the ONP concentration was determined by measuring the 
absorbance values at 415nm using the spectrophotometer. 
6. A blank was prepared in the same fashion as the samples except the cell 
sample was added after the stop reagent to account for turbidity without the 
reaction being carried out. 
7. Enzyme activity was calculated as enzyme units (EU)/gram cells/min using 
Equation (2).  One EU will hydrolyze 1.0 μmole of ONPG to ONP and 
galactose per minute. 
415( )( )
/ min ( )( )( )(100 / )
EU A TotalVolume DilutionFactor
g Time SampleVolume mL g
 (2)  
 
3.2.2.   α  –  Galactosidase  Endpoint  Assay.  A  colorimetric  assay  is  used  to 
measure the enzymatic rate α – Galactosidase cleaves the glycosidic bond of PNPG 
leaving free galactose and PNP.  In dilute concentrations, PNP is yellow in color and is 
detected by a spectrophotometer at 400nm (A400).  Increase in absorbance indicates 
hydrolysis.  The assay is carried out in 100mM sodium phosphate buffer pH 6.8 at 40°C 
and stopped using 120mM sodium tetraborate solution. 
A. Standard Curve Preparation 
1. Standard solution of 10mM PNP was prepared using volumetric glassware by 
dissolving 139 milligrams of PNP (MW 139.1 grams/mole) in enough phosphate 
buffer to make 100 milliliters (mL).  
2. Standard solution of 1mM PNP was prepared by adding 5 mL of 10mM PNP to 
45mL phosphate buffer.  
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3. Standards for measurement were prepared by serial dilution of 1mM PNP 
standard in phosphate buffer to make 1.35mL of the desired concentration 
according to Table 3.3. Each standard was prepared in triplicate.  
4. To mimic assay conditions 0.15 mL phosphate buffer and 3 mL sodium 
tetraborate stop reagent were added to each standard.  The zero standard was used 
to blank the spectrophotometer and absorbance was measured at 400nm using 
1cm quartz cuvettes.  Figure 3.2 shows the standard curve with trend line analysis 
for PNP.  Raw data is given in Appendix A, Table A.2.  
The data was analyzed using ANOVA statistics and linear regression.  Statistical 
results are presented in Table 3.4 and Appendix B.  A P-value of <0.0001 indicates that 
the linear model for ONP concentration is significant.  The standard error can be used as 
the standard deviation as indicated by the R Square value. 
 
 
Table 3.3  Serial Dilutions of PNP Standard Solutions For Standard Curve. 
[PNP] mM 
Volume PNP solution 
(mL) 
Volume phosphate buffer 
(mL) 
0.5 0.675 0.675 
0.4 0.540 0.810 
0.3 0.405 0.945 
0.2 0.270 1.08 
0.1 0.135 1.215 


















Squares Mean Squares F-Value P-value 
Model 1 22.71102 22.71102 48904.85 <0.0001 
Residual 11 0.005108 0.000464 
  
Total 12 22.71613 





Error Lower 95% Upper 95% 
Absorbance 400 5.023392222 0.022715438 4.973395881 5.073388564 
 
Regression Statistics 
Multiple R 0.999887556 
R Square 0.999775124 






The extinction coefficient ( ) for PNP was calculated from the standard curve 
regression using Equation (3) where A400 is the absorbance measurement,  is the slope of 
the linear regression divided by dilution factor (PNP volume (mL)/total assay volume 
(mL)), and l is the path length (1cm).  The experimentally determined value of the 




.  The published literature value of the 




 is outside the 95% confidence interval so 
the experimentally determined value is used for rate calculations. 
 
A400 =  [PNP] l (3) 
 
B. Enzyme Activity Determination 
1. Stock substrate solution of 10mM PNPG was prepared by dissolving 301.3 
milligrams of PNPG (MW 301.3 grams/mole) in 100mL of phosphate buffer.  
Buffer was stored cold in a light protective container.  
2. Cell samples were prepared at 1mg/mL dry cell weight  in phosphate buffer.  
Samples were prepared in duplicate or triplicate depending on the availability of 
sample.  
3. 1.35 mL of 10mM PNPG was dispensed into clean glass tubes and equilibrated 
to 40°C in a circulating water bath.  
4. 0.15 mL of 1 mg/mL cell sample was dispensed into the glass tubes to initiate the 
reaction.  The reaction was carried out at 40°C for 20 – 40 minutes.  
5. After the appropriate amount of time had elapsed, 3 mL of sodium tetraborate 
was dispensed into each tube.  The tubes were removed from the water bath and 
the ONP concentration was determined by measuring the absorbance values at 
415nm using a spectrophotometer.  
6. A blank was prepared in the same fashion as the samples except the cell sample 
was added after the stop reagent to account for turbidity without the reaction 
being carried out.  
7. Enzyme activity was calculated as enzyme units (EU)/gram cells/min using 
Equation (4).  One EU will hydrolyze 1.0 μmole of PNPG to PNP and galactose 





/ min ( )( )( )(100 / )
EU A TotalVolume DilutionFactor
g Time SampleVolume mL g
 (4) 
 
3.2.3.   β  -  Galactosidase  Kinetic  Assay.   Using ONPG as a substrate, purified 
enzyme activity was determined using the kinetic colorimetric assay adapted from  Sigma 
Corporation (St. Louis, MO) protocol SPONPG01 “Enzymatic Assay of β -
Galactosidase”.  Enzyme and substrate solutions were made by adding crystals to 
phosphate buffer adjusted to make a known concentration stock solutions.  Stock 
solutions were made fresh for each experiment.  Test samples were made by serial 
dilution of the stock solution to the desired concentration.  Cuvette volume was 3mL.  
With the exception of data gathered on the effect of temperature on reaction rate, all 
experimental runs were controlled at 37°C by a circulating water bath. 
A. Reagent Preparation 
1. Stock solution of 100mM sodium phosphate buffer pH 7.2 (phosphate buffer) was 
prepared by dissolving the following in deionized (DI) water to make one liter 
then filtering the solution through a 0.2μm filter to remove dust and microbial 
contaminants.  The resulting buffer is pH 7.2±0.2 
 
3.338 grams Na2HPO4●2H2O (MW 177.99 grams/mole) 
13.146 grams NaH2PO4●H2O (MW 137.99 grams/mole) 
 
2. Stock solution of 30mM magnesium chloride reagent was prepared by dissolving 
0.608 grams MgCl2●6H2O (MW 203.31 grams/mole) in 100mL phosphate buffer 
pH 7.2.  Both reagents are stored at room temperature.  
B. Computer Software Interface 
The Agilent 8543 diode array spectrophotometer with UV/VIS Chemstation 
software version A.09.01 with the Kinetics module Biochem Analysis Software was used 
to collect and record data.  A method was created using the following conditions: 
Wavelength – 415nm 
Background Correction – Subtract Average 550-650nm 
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Run Time – 600s (run time changed for tests requiring less or more time) 
Cycle Time – 20s (how often the detector gathers data from the test cells) 
Start Time – 0s (When the detector starts collecting data) 
Kinetic Calculation – Initial Rate Calculation 
The initial rate calculation is determined from the linear portion of the data curve.  
All rate calculations were made using the time point immediately preceding the reaching 
or exceeding the limit of detection as the last data in the linear portion of the curve. 
Before adding samples to the cuvettes a “zero cells” function was performed to 
remove any variations among the quartz cuvettes.  The cuvette tray holds up to eight 
cells.  The software was configured for the number of samples to be run with a blank run 
with each test condition. 
C. Enzyme Activity Determination 
1. Stock substrate solution of 68mM ONPG was prepared by dissolving 0.204 grams 
of ONPG (MW 301.3 grams/mole) in 10mL of phosphate buffer.  Buffer was 
stored cold in a light protective container. 
2. Enzyme stock solution was prepared at 2-4  U/mL in phosphate buffer by diluting 
a stock solution at 3000 U/mL by 1/1000. 
3. Prepare test cuvettes per Table 3.5. 
 
 
Table 3.5  Sample Preparations for Kinetic Experiments of β –Galactosidase (Analysis 
performed by L. Jorgenson, A. Sutterer, and J. Roam). 
  Substrate Concentration (mM) 
 Blank 1.13 2.27 4.53 9.07 18.13 
Phospate 
Buffer 
2.70 ml 2.65 ml 2. 60 ml 2.50 ml 2.30 ml 1.90 ml 
MgCl2 0.10 ml 0.10 ml 0.10 ml 0.10 ml 0.10 ml 0.10 ml 
Enzyme 0.10 ml 0.10 ml 0.10 ml 0.10 ml 0.10 ml 0.10 ml 
Substrate - 0.05 ml 0.10 ml 0.20 ml 0.40 ml 0.80 ml 





4. Immediately before adding the enzyme solution to the cuvettes, start the data 
collection on the software.  Add the enzyme solution to each of the cuvettes 
before the first data point was collected. 
5. Allow the method to run to completion then adjust the calculation range for the 
initial rate based on the data. 
6. Enzyme activity was calculated as enzyme units (EU)/gram cells/min using 
Equation (5).  One EU will hydrolyze 1.0 μmole of ONPG to ONP and galactose 
per minute.   
 
( )( )
/ min ( )( )




3.2.4.   α  –  Galactosidase  Kinetic  Assay.  Using PNPG as a substrate, purified 
enzyme activity was determined using a kinetic colorimetric assay adapted from Bioassay 
Systems protocol POPN006 “pNPP Phosphatase Assay”.  Enzyme and substrate solutions 
were made by adding crystals to phosphate buffer to make a known concentration stock 
solutions.  Stock solutions were made fresh for each experiment.  Test samples were 
made by serial dilution of the stock solution to the desired concentration.  Cuvette 
volume was 3mL.  For each data point a blank was made consisting of 1.5mL of the 
PNPG solution and 1.5mL of phosphate buffer in place of enzyme solution.  With the 
exception of data gathered on the effect of temperature on reaction rate, all experimental 
runs were controlled at 25°C by a circulating water bath. 
A. Computer Software Interface 
The Agilent 8543 diode array spectrophotometer with UV/VIS Chemstation 
software version A.09.01 with the Kinetics module Biochem Analysis Software was used 
to collect and record data.  A method was created using the following conditions: 
Wavelength – 400nm 
Background Correction – Subtract Average 550-650nm 
Run Time – 1800s (run time changed for tests requiring less or more time) 
Cycle Time – 30s (how often the detector gathers data from the test cells) 
Start Time – 0s (When the detector starts collecting data) 
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Kinetic Calculation – Initial Rate Calculation 
The initial rate calculation is determined from the linear portion of the data curve.  
All rate calculations were made using the time point immediately preceding the reaching 
or exceeding the limit of detection as the last data in the linear portion of the curve. 
Before adding samples to the cuvettes a “zero cells” function was performed to 
standardize the lamp against any noise that may be introduced by the quartz cuvettes.  
The cuvette tray holds up to eight cells.  The software was configured for the number of 
samples to be run with a blank run with each test conditon. 
B. Enzyme Activity Determination 
1. Prepare the appropriate dilutions of the enzyme and substrate solutions. 
2. Dispense 1.5 mL of the non variable solution into each of the cuvettes (ie if 
testing changing enzyme concentrations then substrate concentration is the non 
variable).  When testing temperature effects add either substrate or enzyme but do 
not mix the solutions until ready to begin measurements.  
3. Immediately before adding the variable solution to the cuvettes start the data 
collection on the software.  Add 1.5 mL of the variable solution to each of the 
cuvettes before the first data point is collected.  
4. Allow the method to run to completion then adjust the calculation range for the 
initial rate, based on the data.  A typical data plot is shown in Figure 3.3. 
5. Enzyme activity was calculated as enzyme units (EU)/mg enzyme/min using 




/ min ( )( )( )
EU Rate TotalVolume DilutionFactor
mg SampleVolume EnzymeConcentration












3.3. DRY-CELL WEIGHT DETERMINATION 
Cell growth was determined by measuring the turbidity of the culture broth with 
time.  The optical density (OD) probe was a Fundalux II detecting at wavelength 910nm 
used in conjunction with a Biostat
®
 B Plus two-liter bioreactor with a 1.5 liter working 
volume. Micro DCU system software was used to control the bioreactor and record time 
point data of the cultures.  An increase in turbidity indicated an increase in the number of 
cells present in the reactor.  A set of standards were made using Bifidobacteria bifidum 
NCIMB41171.  A 10 gram/liter cell slurry was made by weighing out three grams of 
freeze dried cells and mixing with 300 milliliters sodium phosphate buffer.  The cell 
slurry was allowed to stir for 30 minutes to ensure a homogenous mixture.  Serial 
dilutions of the 10 gram/liter solution were made as shown in Table 3.6 for the standard 
curve.  A total of 20mL was needed for each measurement.  All standards were made in 





Table 3.6  Serial Dilutions of 10g/L NCIMB41171 Cell Slurry. 
Cell Density (g/L) Volume Cell Slurry (mL) 
Volume phosphate buffer 
(mL) 
7.5 15 5 
5 10 10 
4 8 12 
3 6 14 
2.5 5 15 
2 4 16 
1.5 3 17 
1 2 18 
0.5 1 19 
0.25 0.5 19.5 
0.1 0.2 19.8 
Blank 0 20 
 
 
The data follows a nearly exponential curve in the form shown in equation 7 
however this model does not hold true at cell densities below 1gram/liter.  Cell densities 
at or below 1 gram/liter are analyzed using linear regression (8) while cell densities 
greater than 1 gram per liter are analyzed using the exponential fit (7) where C and M are 
constants found through regression and OD is the optical density.  Figure 3.4 shows the 
standard curve used for determining dry cell weight. 
 
Cell Density > 1 gram/liter: 
OD910
  e = *Cell DensityC M  (7) 
 








Figure 3.4 Dry Cell Weight Standard Curve.  Linear Fit (Turbidity = 0.037635 + 




The data was analyzed using ANOVA statistics and linear and nonlinear 
regression.  Statistical results are presented in Table 3.7, Table 3.8 and Appendix B.  A P-
value of <0.0001 indicates that the models for cell density are significant.  The standard 
error can be used as the standard deviation as indicated by the R Square value. 
 
 






Squares Mean Squares F-Value P-value 
Model 1 2.5858120 2.58581 2847.803 <.0001 
Residual 11 0.0099880 0.00091   
Total 12 2.5958000    
 
Regression Statistics 
R Square 0.999004 










Squares Mean Squares F-Value P-value 
Model 1 248.19015 248.190 19059.70 <.0001 
Residual 19 0.24741 0.013   
Total 20 248.43756    
 
Regression Statistics 
R Square 0.995026 
Standard Error 0.019969 
 
 
3.4. SUGAR ANALYSIS BY HPLC 
Sugars were analyzed using a Phenomenex Rezex-RCM ion exchange column in 
calcium form on an Agilent HP 1090 high performance liquid chromatograph (HPLC) 
using Chemstation A.03 software. The mobile phase was Milli-Q® water (18 mega-ohm 
resistivity) at 0.6 mL/min flow rate. The column temperature was controlled at 85
0
C. The 
detector was an Agilent 1037 refractive index detector operated at 40
0
C. The injection 
size was 10 µL for all samples and each sample is injected in duplicate.  The Chemstation 
software calculates the area under the curve and generates calculated concentrations for 
each mixuture. 
Standard Curve Preparation 
Standard solutions A and B were prepared per Table 3.9 by O. Sitton.  Standard A 
is a mixture of four oligosaccharides: maltohexaose (DP6), maltopentaose (DP5), 
maltotetraose (DP4) and maltotriose (DP3).  Standard B is a mixture of lactose, glucose, 
and galactose.  Injection samples are 500 microliter volumes made up of differing ratios 
of A and B with known concentrations of each sugar.  Figure 3.5 is an example 
chromatograph showing typical retention times for each sugar.  The known 
concentrations are the expected values which the HPLC results are being compared to for 






Table 3.9  Standard Solution Sugar Concentration. 
 
Sugar Concentration (gram/Liter) 
Standard DP6 DP5 DP4 DP3 Lac Glc Gal 
A 9.91 9.45 9.82 20.4 - - - 















Figure 3.5  Sample HPLC Chromatagraph with Rention Time for Each Sugar. 





































































Table 3.10  Expected Sugar Concentrations for Samples. 
 




DP6 DP5 DP4 DP3 Lac Glc Gal 
100:0 9.91 9.45 9.82 20.4 - - - 
90:10 8.92 8.51 8.84 18.36 10.21 5.13 5.30 
80:20 7.93 7.56 7.86 16.32 20.42 10.27 10.59 
70:30 6.94 6.62 6.87 14.28 30.62 15.40 15.89 
60:40 5.95 5.67 5.89 12.24 40.83 20.53 21.18 
50:50 4.96 4.73 4.91 10.2 51.04 25.67 26.48 
40:60 3.96 3.78 3.93 8.16 61.25 30.80 31.78 
30:70 2.97 2.84 2.95 6.12 71.46 35.93 37.07 
20:80 1.98 1.89 1.96 4.08 81.67 41.06 42.37 
10:90 0.99 0.95 0.98 2.04 91.87 46.20 47.66 
0:100 - - - - 102.08 51.33 52.96 
 
 
The data was analyzed using ANOVA statistical analysis.  Lactose is determined 
using a quadratic fit.  Glucose and galactose are determined using a linear fit.  Figure 3.6 
shows the standard curves and their statistical results are presented in Table 3.11.  A P-
value of <0.0001 indicates that the models for concentration is significant.  The standard 
error can be used as the standard deviation as indicated by the R Square value.  These 
















Squares Mean Squares F-Value P-value 
Lactose 
    
 
Model 2 221148151 110574076 6886.007 <.0001 
Residual 27 433560 16057.793 
 
 




    
 
Model 1 82665096 82665096 36767.46 <.0001 
Residual 28 62953 2248.3221 
  
Total 29 82728049 
   
Galactose 
     
Model 1 83899719 83899719 33356.97 <.0001 
Residual 28 70426 2515.2082 
  
Total 29 83970145 




Lactose Glucose Galactose 
R Square 0.998043 0.999239 0.999161 




3.5. MEDIA PREPARATION FOR ANAEROBIC CELL CULTURE 
Bifidobacteria require an anaerobic growth environment.  Media was prepared as 
follows for culture tubes and vials. 
1. Dissolve media components in Milli-Q® water so that the flask contains not more 
than 75% of the maximum flask volume.  Mix by magnetic stirring.  For media with 
high sugar concentration prepare the sugar and nitrogen components separately at 
appropriate concentrations such that they are the correct concentrations when mixed 
for the final media. 
2. Stop stirring and allow the liquid to come to rest.  Mark the liquid edge on the 
outside of the flask.  Add 10-20mL additional water to account for liquid that will be 
lost during the oxygen purging process.  
3. If necessary add methylene blue as an oxygen indicator at 5 milligrams/liter.  
4. Turn on the Thermalene® 2110 Tube Furnace and set the temperature to 260°C.  
Allow the furnace to come to temperature. 
5. Strip the furnace of oxygen by flowing “forming” gas (90:10, N2: H2) through the 
heater for 10 minutes.  Stop flowing “forming” gas. 
6. Purge “forming” gas from the heater by flowing “purge” gas (80:20, N2: CO2).  This 
gas is used to purge the oxygen from the media and fill the headspace in the flask. 
7. Gently heat the media while stirring slowly using magnetic stirring.  If methylene 
blue is present in the media a lack of blue color indicates oxygen free media. 
8. Place a rubber stopper with holes for gas delivery and venting in the flask opening as 
in Figure 3.7.  Ensure the tip of the gas delivery tube is just above the liquid level 
and the end of the vent tube is as close to the bottom of the rubber stopper as 








Figure 3.7  Oxygen Purge Setup for Anaerobic Media Preparation. 
 
9. Continue heating and gently stirring the flask allowing the liquid to come to a low 
boil.  Stirring is not necessary however if a stir bar is present it will act as a boiling 
stone in the bottom of the flask. 
10. Direct the purge gas to the gas delivery tube and purge the oxygen from the media 
and the flask head space for a minimum of 15-20 minutes.  Continue to heat the 
system with gas flow until the volume in the flask reaches the mark made in step 2. 
11. Remove the deoxygenated media from the heat source.  While the media is still hot 
exchange the rubber stopper for a solid stopper and seal the container airtight. 
12. Transfer the flask to the anaerobic chamber and allow the liquid to cool. 
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13. Dispense the cooled anaerobic media into clean vials and culture tubes which have 
been equilibrated in the anaerobic chamber for a minimum of 24 hours.  Cap tubes 
and vials airtight. 
a. For media with high sugar concentration and nitrogen components prepared 
separately, keep the solutions separate and seal the containers airtight for 
autoclaving. 
b. Prepare clean empty vials and tubes, sealed airtight for autoclaving, for media 
preparation after sterilizing the components separately. 
14. Sterilize the prepared containers and media in an autoclave for 15-20 minutes at 
121°C. 
15. Remove the sterile media and containers from the autoclave while still hot.  Transfer 
the containers and media to the anaerobic chamber and allow to cool completely. 
a. Mix media components in the prepared containers to the correct concentrations 
while still warm to the touch but not hot. 
16. Label the tubes and vials with the contents and store at room temperature until ready 
to use. 
 
Media was prepared as follows for the two-liter bioreactor. 
1. Dissolve the media components in Milli-Q® water keeping the carbohydrates 
separate from the nitrogen components.  Divide the volume into halves and make 
each half 2X concentration.  Final volume for most cultures is one liter. 
2. If necessary add methylene blue as an oxygen indicator at 5 milligrams/liter. 
3. Prepare a 250 milliliter bottle of 1N sodium hydroxide (NaOH). 
4. Prepare a 250 milliliter bottle of antifoam solution. 
5. Standardize the reactor inline pH probe with pH buffers 4.01 and 7.00. 
6. Ensure the reactor is clean then add either the prepared nitrogen based solution or the 
prepared carbohydrate based solution to the reactor vessel. 
7. Put the lid on the reactor and loosely fasten the bolts to hold down the lid. 
8. Close or clamp all the ports on the reactor. 
9. Put in place the pH probe, the turbidity probe, the antifoam sensors, the oxygen 
sensor and the septum. 
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10. Sterilize the reactor, remaining media component, sodium hydroxide solution and 
antifoam in an autoclave for 30 minutes at 121°C. 
11. Remove reactor and other components from the autoclave. 
12.  Connect the antifoam and sodium hydroxide solution through the Biostat Bplus 
pump to the reactor feed ports. 
13. Tighten down the reactor lid and unclamp the necessary ports for venting and feed 
solutions. 
14. Attach all ancillary components of the reactor. 
a. Attach the water jacket hoses and begin cooling the reactor to 50°C. 
b. Attach the agitator motor and turn on at 100rpm to assist in the cooling of 
the reactor contents. 
c. Attach gas tubes to gas inlet ports and unclamp ports. 
d. Attach off-gas condenser. 
e. Attach all sensor cables. 
15. As aseptically as possible, transfer the remaining media component to the reactor 
through one of the addition ports. 
16. Allow “beer gas” (75:25, N2:CO2) flow at low flow to purge oxygen from the media 
and create a N2/CO2 blanket in the headspace of the reactor.  Purge for a minimum 
of one hour. 
17. Adjust the control temperature of the reactor to 37°C. 
18. Using the pump on the Biostat B Plus gradually add sodium hydroxide solution to 
reach the desired pH. 
19. Allow the reactor to stir at 37°C overnight to verify sterility and ensure the media is 
anaerobic. 
20. Zero the optical density probe. 
 
3.6. ANAEROBIC CELL CULTURE 
Cells were cultured anaerobically at 37°C for a minimum of 12 hours.  Cells 
cultured in tubes or vials were gently stirred using an incubating shaker or mixed 
periodically by hand to minimize the effects of nutritional micro environments.  Cells 
cultured in the Biostat® B plus were mixed using the unit agitator at 150 Rpm and 
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sparged with beer gas (75:25, N2:CO2) to keep the culture oxygen free and the reactor 
under positive pressure.  Cultures were inoculated with 1% total volume using cultures in 
exponential growth phase.  To verify aseptic technique for vial and tube preparations a 
blank tube was inoculated with sterile media and incubated under the same conditions. 
For cultures in tubes and vials pH was not controlled however final pH was 
recorded. In the bioreactor pH was measured, recorded and in some cases controlled 
during the culture lifecycle.  Cultures were stored at 4°C to serve as future inoculum or 
for additional testing. 
3.7. CELL CULTURE CONDITIONS 
In order to understand how changes in culture media influenced cell growth, B. 
bifidum ATCC 700541 was cultured on enhanced reinforced clostridial medium (RCM) 
as a reference media.  A cell bank was started from a single ampule of freeze dried cells 
and anaerobically cultured using RCM with no additional components through two 
inoculation cycles before being used to seed batch cultures for evaluation.  Table 3.12 
lists the formula for the enhanced RCM.  For comparison batch cultures in the Biostat
®
 B 
Plus were cultured with and without pH control.  Batches that were controlled were held 
at pH 6.5 – 6.8 using 1N sodium hydroxide. 
Since B. bifidum readily utilizes glucose as a carbohydrate source, cells were 
grown on the reference media with increased glucose concentrations in attempt to find a 
cell density limit for the culture. 
One of the challenges to using Bifidobacteria cells for the GOS transformation 
reaction is they are a species that is especially difficult to grow on a purely synthetic 
medium.  The desire to culture the organisms on synthetic media is purely economic.  
The more components a medium has the more expensive it is to use.  Two synthetic 
media modified from the Norris Medium were chosen in attempts to culture B. bifidum 
ATCC 700541 using minimal medium components.  The formulas for each of the 
selected media can be found in Table 3.13, Table 3.14, and Table 3.15.  Since the 
minimal media did not contain any glucose, complex amino acids or vitamins the cultures 
needed to be gradually introduced to the medium by stepping down from the RCM by a 




Table 3.12  Difco™ Reinforced Clostridial Medium (RCM). 
Media Component 
Approximate Formula 
Grams Per Liter 
Pancreatic Digest of Casein 5.0 
Proteose Peptone No. 3 5.0 
Beef Extract 10.0 
Yeast Extract 3.0 
Dextrose (glucose) 5.0 
Sodium Chloride 5.0 
Soluble Starch 1.0 
Cysteine Hydrochloride 0.5 
Sodium Acetate 3.0 
Agar 0.5 
Components Added (Enhanced RCM) 
Potassium phosphate, dibasic 4.5 




Table 3.13  Minimal Media (Bezkorovainy and Miller-Catchpole 1989). 
Media Component 
Approximate Formula 
Grams Per Liter 
Ammonium Acetate 4 
Sodium Acetate 50 
Potassium phosphate, dibasic 5 
Cysteine 0.4 
Lactose 70 
Biotin 0.008 mg 
Calcium Pantothenate 0.8 mg 





Table 3.14  Modified Minimal Media (Bezkorovainy and Miller-Catchpole 1989). 
Media Component 
Approximate Formula 
Grams Per Liter 
Ammonium Acetate 4 
Potassium phosphate, dibasic 5 
Lactose 70 
Cysteine 0.4 
Tween® 80 2 
Calcium Pantothenate 0.8 mg 
Biotin 0.008 mg 
Ascorbic Acid 0.02 




Table 3.15  Salts B Solution (Bezkorovainy and Miller-Catchpole 1989). 
Media Component 
Approximate Formula 
Grams Per 250 mL 
Magnesium Sulphate Heptahydrate 10 
Iron Sulphate Heptahydrate 0.5 
Sodium Chloride 0.5 








Volume Minimal Media 
(mL) 
100:0 15 0 
67:33 10 5 
33:67 5 10 
0:100 0 15 
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Cell growth was determined by a drop in pH from the starting media after a 24 
hour incubation. The results were compared to growth in the RCM.  Table 3.17 is a 
summary of the cell adaptation.  The two media conditions chosen were termed “minimal 




Table 3.17  Cell Adaptation Summary Table. 
Media Starting pH Ending pH 
RCM 6.61 4.46 
1/3 Minimal Media, 2/3 RCM 6.80 4.60 
2/3 Minimal Media, 1/3 RCM 6.91 4.85 
Minimal Media 6.99 6.79 













4.1. CELL GROWTH ON REFERENCE MEDIA 
In order to understand how changes in culture media influenced cell growth B. 
bifidum ATCC 700541 was cultured on enhanced reinforced clostridial medium (RCM) 
as a reference media.  For comparison batch cultures in the Biostat
®
 B Plus were cultured 
with and without pH control.  Batches that were controlled were held at pH 6.5 – 6.8 
using 1N sodium hydroxide.  Figure 4.1 shows the growth profile of the biostat culture 






Figure 4.1  Time-Course of Cell Growth in Reference Medium Without pH Control. 
 
 
B. bifidum readily cells were also grown on the reference media with increased 
glucose concentrations in attempt to find a cell density limit for the culture.  Results are 







































Figure 4.2  Time-Course Plot of Cell Growth in Reference Medium for Increasing 





Table 4.1  Reference Media Cell Culture Data Summary. 







10 2.0 0 
30 4.1 20 




From this plot it can be seen that increasing glucose allows the culture to reach a 
greater cell density than in the reference culture.  As can be expected the cells grown in 
media containing 50 g/L glucose have a higher growth rate during the exponential phase 
and they remain in lag phase for a greater amount of time but they reach a greater cell 
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density overall.  Both the 30 g/L and 50 g/L glucose seem to move into stationary phase 
at approximately the same time indicating that there is either the depletion of a nutritional 
component limiting further growth or there is an accumulation of a metabolite which 
inhibits growth.  HPLC analysis of broth samples from the end of each fermentation 
show an excess of glucose remaining in the medium.  A comparison plot of a pH 
controlled fermentation and non controlled fermentation is shown in Figure 4.3.  During 
the pH controlled run there was a disruption of base addition however once the system is 
brought back under control it recovers and continues to increase in cell density.  Figure 






Figure 4.3  Comparison of a pH Controlled Batch Fermentation with a non pH Controlled 







4.2. CELL GROWTH ON TEST MEDIA 
One of the challenges to using Bifidobacteria cells for the GOS transformation 
reaction is they are a species that is especially difficult to grow on a purely synthetic 
medium.  As expected the cells did not readily grow on the purely synthetic media.  For 
both the minimal media and the modified minimal media the drop in pH could possibly 
be attributed to the effect of the low pH inoculum however, the modified minimal media 
which was originally formulated to grow cells in suspension and on solid media did have 
some turbidity after the incubation period 
After adapting the cells to the minimal media an attempt to grow the cells on the 
two media was made over a 6 day incubation period.  The time progression data is shown 
in Table 4.2. 
 
 
Table 4.2  Synthetic Media Growth Study Results. 
Media Day pH Cell Density (g/L) 
Minimal Media RCM 0 7.04 - 
 1 6.94 - 
 2 6.93 - 
 3 6.94 - 
 4 6.85 - 
 5 6.85 - 
 6 6.85 0.005 
Modified Minimal 
Media 
0 7.31 - 
 1 6.95 - 
 2 6.91 - 
 3 6.52 0.005 
 4 6.16 0.017 
 5 5.57 0.124 




The results of this trial show that this strain of Bifidobacteria requires media 
enhancements such as the bifid factors of yeast extract in order to be able to grow for 
GOS production. 
Bifidobacteria bifidum NCIMB41171 has been successfully cultured using a 
medium containing yeast extract, meat extract and tryptone.  The media used by Goulas 
et al. were selected as media for enumeration and enzyme production.  The media are 
termed “propagation medium” and “enzyme medium” and their formula can be found in 
Table 4.3.  Cells were adapted to the media by culturing them in enhanced RCM with 10 
grams per liter lactose added to the media.  A cell bank was started by culturing the cells 
through two inoculation cycles on propagation medium before being used to seed batch 
cultures for evaluation.  The cells were cultured in a similar fashion as with the reference 
media.  The growth curves for each media are presented in Figure 4.4. 
 
 
Table 4.3  B. bifidum media.  Approximate Formula Grams Per Liter (Tzortis et al. 2005). 
Media Component Propagation Enzyme 
Tryptone 15 7.5 
Meat Extract 2.5 7.5 
Yeast Extract 7.5 7.5 
Potassium phosphate, dibasic 4.5 2 
Cysteine Hydrochloride 0.05 0.5 
Lactose 2.5 4 
Glucose 7.5 6 








Figure 4.4  Time-Course of Cell Growth in Propagation and Enzyme Media.  Reference 
Media is 10 g/L Glucose.  Batches are pH Controlled. 
 
 
From this plot it can be seen that this strain of Bifidobacteria responds very well 
to the bifid factors in the media with the same sugar concentration as in the reference 
medium.  The cells grown in propagation medium reach a maximum cell density of 6.5 
grams per liter and the cells grown in enzyme cell medium reach a level of 4.8 grams per 
liter.  Both media outperform the RCM at all glucose concentrations. 
Using the propagation medium, a study was performed to look at varying the 
concentration of lactose for growth and how it affected cell growth and enzyme activity.  
The concentrations selected for study were 10g/L, 30 g/L, 50 g/L, 100 g/L and 250 g/L 
(1%, 3%, 5%, 10%, and 25%) lactose with glucose concentration constant at 7.5 g/L.  For 
each lactose concentration a set of eight culture tubes were prepared.  The initial pH of 
the medium was not adjusted prior to inoculation and the pH of the cultures was not 
adjusted during the study.  All the tubes were inoculated with 1% inoculum at the same 
time from the same base culture and incubated at 37°C for the duration of the trial.  
Samples were taken by removing a tube from the incubator and measuring the turbidity 
and pH immediately.  Figure 4.5 shows the growth curves of each of the lactose 




Figure 4.5  Cell growth of B. bifidum ATCC 700541 on Varying Concentrations of 




Table 4.4  Lactose in Propagation Media Results. 
 



























 8 6.85 0.175 6.39 0.586 5.59 1.116 4.99 1.261 6.04 0.096 
10 6.38 0.745 5.62 1.187 4.75 2.624 4.75 2.009 6.06 0.056 
11 5.54 1.261 5.31 1.543 4.67 2.802 4.62 2.402 6.05 0.056 
12 5.13 1.793 4.77 2.682 4.59 2.991 4.5 2.483 5.81 0.096 
13 4.74 2.802 4.67 2.927 4.51 2.802 4.54 2.511 5.59 0.162 
16 4.56 2.991 4.57 3.124 4.49 3.024 4.47 2.429 5.42 0.228 
18 4.54 3.023 4.48 3.124 4.42 3.090 4.41 2.298 5.11 0.401 
37 
        
4.38 1.143 
 
Looking at the data it appears that cells grown on 1%, 3% and 5% reach a 
maximum cell density of approximately 3 g/L and a minimum pH of 4.4 – 4.5.  The 
initial growth rate increases as the lactose concentration increases until the concentration 
exceeds 10% then it appears that the cell growth is inhibited by the concentration of sugar 





























4.3. CELLULAR BETA GALACTOSIDASE ACTIVITY 
In order to determine if Bifidobacteria bifidum ATCC 700541 is an economically 
viable option for producing GOS, the amount of β-galactosidase activity by the cells is 
determined by an endpoint colorimetric assay.  The cells were separated from the 
fermentation broth by centrifugation and resuspended in phosphate buffer at 
approximately 1mg/mL cell density.  The activity of the cells cultured on propagation 
medium was found to be 10.94 EU/gram/min.  The activity of the cells cultured on 
enzyme medium was found to be 23.61 EU/gram/min.  For comparison Bifidobacteria 
bifidum NCIMB 41171 cells were tested and found to have activity levels of ~400 
EU/gram/min.  The time point data from the 1% and 3% samples in the lactose growth 
study were tested for β-galactosidase activity.  As can be seen in Figure 4.6 in the 1% 
samples β-galactosidase activity increases with time whereas in the 3% samples the 





Figure 4.6  β-Galactosidase Activity and Cell Density of B. bifidum ATCC 700541 
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4.4. CELLULAR ALPHA-GALACTOSIDASE ACTIVITY 
Bifidobacteria which have α-galactosidase activity make it possible for the cells 
to utilize alpha-linked sugars and if the α-galactosidase has transgalactosylation 
capabilities the organism can be used to make alpha-linked GOS molecules from lactose.  
To determine if B. bifidum ATCC 700541 had α-galactosidase activity the 1% culture 
from the lactose growth study was tested using the α-galactosidase endpoint assay.  






Figure 4.7  α-Galactosidase Activity of B. bifidum ATCC 700541 Cultured With 1% 
Lactose in Propagation Medium. 
 
As was seen with β-galactosidase there is an increase in activity with time.  Cells 
cultured on enzyme medium expressed similar levels of activity as those cultured on 
propagation medium.  The α–galactosidase activity of B. bifidum ATCC 700541 was 































4.5. UNBOUND ENZYMEACTIVITY 
In order to compare the economics of making GOS using Bifidobacteria bifidum a 
baseline for comparison is established by determining the rates for the unbound enzymes.  
The enzyme activities for both galactosidases were determined experimentally by 
reacting a constant enzyme concentration with varying substrate concentrations.  
Michaelis–Menten kinetics (9) were used as the model and plotted using an Eadie–
Hofstee diagram to determine Vmax (10) and Km (11).  Figure 4.8 and Figure 4.9 show 
the saturation curves for α-galactosidase and β –galactosidase respectively and Figure 













































































































From these plots, it is determined that Vmax is 395.69 EU/mg/min and Km is 
0.7907 mM for α-galactosidase and Vmax is 681.73 EU/mL/min and Km is 1.4729mM 
for β –galactosidase.  As has been determined, temperature and pH influence the rate of 
reaction.  The GOS production reaction is carried out at 40°C, pH 6.5 – 7.2.  The cellular 
bound enzymes and the unbound β –galactosidase enzyme kinetics were determined 
using these conditions however the α-galactosidase kinetics were determined at a much 
lower temperature.  The α-galactosidase is not the primary enzyme of interest however it 
is important to see how temperature and pH will affect the reaction rate.  Figure 4.12. 
shows the relationship of temperature and pH on enzyme reaction rate for α-
galactosidase.  It is clear from this graph that enzyme activity increases with temperature 
and pH has an optimum at pH 6.8 – 7.0.  At 40°C the enzyme activity is 2.5 times the 
activity at 25°C. 
 
 

























Figure 4.12  Effects of pH and Temperature on α-Galactosidase at 0.01mg protein/mL 




4.6. ECONOMIC ANALYSIS 
The costs for batch production of GOS by B. bifidum ATCC 700541 was 
calculated using the β-galactosidase activity found in this study.  Tzortzis et al. describe a 
GOS process using 40% lactose in 100mM phosphate buffer with enough cell mass to 
provide 850 EU in 100 mL of solution.  The cells are recycled and used eight times with 
10% loss of activity after each synthesis batch.  This process yields 80-85% lactose 
conversion with a GOS yield of 28 - 30%.  These conditions provide the basis for 
calculation of GOS production.  Using the yield numbers from whey permeate reported 
by Tzortzis a reactor needs to be batched with 8,600 U β-galactosidase /L to produce 130 
- 150 g/L GOS.  Dosing the reaction at this level the α-galactosidase levels in the mixture 
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loss ratio of 15% per cycle.  Table 4.5 details the costs for GOS production using B. 
bifidum ATCC 700541 and Table 4.6 details the costs for GOS production using unbound 
enzymes.  Prices for raw materials were obtained from common distributers of chemicals 
and media components. 
 
 








Propagation 6.5 154 $ 402.30 $ 618.92 
Enzyme 4.5 222 $ 398.32 $ 885.16 
     
Cost Without 
Cell Reuse 
β –gal U/kg 
β –gal U/100L 
GOS Batch 




Propagation 1.1 x 10
4
 8.6 x 10
5
 78.2 $48,400 
Enzyme 2.36 x 10
4
 8.6 x 10
5
 36.4 $32,220 
     
Cost With Cell 
Reuse 




α –gal U/kg 
α –gal U/100L 
GOS Batch 
Propagation 78.2 $12,100 - - 
Enzyme 36.4 $8,055 6.37 x 10
3















β –galactosidase 681 1263 $28 $35,364 





The ability to regulate human health through manipulation of the intestinal 
microbiota has become an area of intense study.  A particular area of study is the use of 
prebiotics to selectively promote the growth of beneficial bacteria which are indigenous 
to the lower intestines.  Specifically, the use of galactooligosaccharides (GOS) has been 
used to target species of Bifidobacteria. 
Synthesis of GOS using β –galactosidase is presently the most feasible industrial 
synthesis method due to the availability and cost of the starting material, lactose rich 
cheese whey.  β –galactosidase hydrolyzes lactose and transfers galactose to another 
carbohydrate unit or water.  GOS are formed when galactose are transferred to another 
carbohydrate.  Transfer to a water molecule results in complete hydrolysis and monomer 
sugar units (Pazur 1954; Juers et al. 2001).  It has been shown that in order to increase the 
transgalactosylation reaction a high concentration of lactose must be present in solution 
so that lactose is the preferred receptor for the galactose (Hsu et al. 2007). 
GOS synthesis can be carried out using cellular bound enzymes or purified 
enzymes.  Research indicates that Bifidobacteria in the lower intestine show a preference 
for GOS synthesized using enzymes from a homologous source (Rabiu et al. 2001).  
Work done by Tzortis et al. show that Bifidobacterium bifidum NCIMB 41171 produces a 
GOS mixture that promotes increased levels of indigenous Bifidobacteria growth as well 
as increases in short chain fatty acid production.  The strain exhibited both β –
galactosidase and α –galactosidase which produced a unique mixture of GOS (Tzortis et 
al. 2005).  We investigated B. bifidum ATCC 700541 using substrate analogs to 
determine if it had similar enzyme activity characteristics.  The findings were then 
compared to the activity levels of purified enzymes from E. coli and A. niger to 
determine the economic feasibility of further investigating B. bifidum ATCC 700541 as a 
GOS producing organism. 
The most cost effective media for cell culture would be a simplified media which 
contained no complex vitamins, amino acids or protein fractions to enhance growth.  
Previous work shows that Bifidobacteria are difficult to culture on minimal media 
however, each strain of Bifidobacterium behaves differently under the same culture 
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conditions.  Results from our study show that B. bifidum ATCC 700541 does not grow or 
has limited growth using minimal media.  In an experiment performed over 8 days 




 days of the experiment.  Growth 
was significantly less than 1 g/L which would not be cost effective considering the 
volume that would be necessary to attain the number of cells that would be necessary for 
GOS production. 
Most Bifidobacteria require growth promoting factors termed “bifid” factors to 
enhance growth.  These factors include milk casein fractions, yeast extract, and complex 
amino acid mixtures.  Two media used by Tzortis et al. were selected to culture the cells.  
B. bifidum ATCC 700541 responded very well to both the culture media.  Each medium 
contained different levels of yeast extract, meat extract and tryptone.  The media were 
termed “propagation medium” which yielded 6.5 g/L cell mass and 10.94 EU/g cells β –
galactosidase activity and “enzyme medium” which yielded 4.5 g/L cell mass and 23.6 
EU/g cells β –galactosidase activity.  The level of cell mass when compared to B. bifidum 
NCIMB 41171 are in the same range or possibly higher; however, the level of β –
galactosidase activity is much lower. 
Work by Astapovich and Ryabaya show a relationship between the types of sugar 
in the culture medium and growth rate.  There has also been work that has shown β –
galactosidase activity over time and its association with growth.  B. bifidum ATCC 
700541 was cultured using different levels of both glucose and lactose on a commercially 
prepared medium as well as the enzyme medium to compare growth on the sugars as well 
as the enzyme activity during growth.  Cells were cultured on the prepared medium with 
only glucose at 3% and 5% the end samples were analyzed using HPLC.  Each culture 
had differing growth rates but in both cases there was an excess amount of glucose 
present indicating that the sugar concentration was not the only factor in the increased 
growth.  In the “enzyme” medium, the culture had a glucose level held constant with 
differing levels of lactose.  The levels of lactose in the medium also showed an increase 
in growth rate with an increase in concentration.  Cells grown at 1% and 3% lactose were 
then tested for enzyme activity and it is clear that at 1% the level of activity increases 
with growth however at 3% the level remains fairly constant.  The cells in the 3% culture 
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reaches stationary phase sooner than the cells in the 1% medium and this could be a 
reason for this observation. 
The current method for GOS production is to use a purified enzyme extracted 
from a fungal or bacterial source.  The enzymes can only be used a single time since the 
termination step in the GOS reaction is to heat denature the enzyme.  To determine if B. 
bifidum ATCC 700541 is an economically feasible strain to use for GOS conversion the 
enzyme levels determined are compared to purified enzymes.  The activity levels of an α 
–galactosidase and a β –galactosidase were determined using kinetic assay 
measurements.  Looking at the primary functioning enzyme, β –galactosidase , and 
comparing the two sources of enzymes, bound and unbound, enzymes bound in B. 
bifidum ATCC 700541 are as cost effective as the unbound enzymes.  In order to be an 
economically viable solution growing the cells needs to be more cost effective than the 
enzymes.  In order for this to be a possibility the costs were compared using data from 
Tzortis et al. with 15% loss per cycle.  Using this assumption in calculation the B. 
bifidum ATCC 700541 becomes a viable option, with further research, as a candidate for 
GOS conversion.  Looking also at the α –galactosidase activity levels between B. bifidum 
ATCC 700541 and B. bifidum NCIMB 41171, there is significantly more α –
galactosidase present in B. bifidum ATCC 700541.  The overall effect this would have in 
the GOS conversion reaction needs to be investigated. 
To fully understand the potential of B. bifidum ATCC 700541 as an organism for 
GOS production investigation into several factors is still necessary.  Some of the factors 
to determine viability for production include: determining what media components cause 
increases in enzyme activity during cell culture and an evaluation of tradeoff between 
enzyme expression and cell mass, metabolites in the culture media that cause growth 
inhibition, gaining an understanding of how α –galactosidase activity present in B. 
bifidum ATCC 700541 differs from α –galactosidase activity present in B. bifidum 
NCIMB 41171 and what are the overall effects on the GOS mixture, determining if there 
is any method of treatment for the cells which would open the cell wall to gain access to 
β –galactosidase activity inside the cell, and verification of actual loss of activity levels 




The investigation into the growth characteristics of this organism shows that B. 
bifidum ATCC 700541 cannot be cultured on a medium that does not contain bifid 
factors.  The complex media presented in this work will culture B. bifidum ATCC 700541 
with β –galactosidase activity.  The studies indicate the following: 
 Sugar type and concentrations are important for growth and enzyme production in 
the culture. 
 Nitrogen growth components type and concentrations are important for producing a 
cell culture suitable for GOS production. 
 Under non-optimized growth conditions and measured enzyme activity levels using 
the substrate analog ONPG, B. bifidum ATCC 700541 can be considered as an 
organism for GOS production. 
 Optimization work should be done to find the right culture conditions which achieve 
a balance between cell mass and enzyme activity level to produce a culture 







DATA TABLES FOR STANDARD CURVES  
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This appendix contains data used to generate standard curves for enzyme activity, 
dry cell weight determination and sugar analysis by HPLC. 
 
 
Table A.1  Absorption Data, 415nm for ONP Standard Curve. 
[ONP] 




1 1.286 1.2622 1.2829 1.27703 
 
0.0129 
0.9 1.1733 1.1759 1.1666 1.17193 
 
0.0048 
0.8 1.0414 1.0037 1.0389 1.02800 
 
0.0211 
0.7 0.88272 0.88213 0.89317 0.88601 
 
0.0062 
0.6 0.76014 0.76464 0.76916 0.76465 
 
0.0045 
0.5 0.63333 0.6407 0.64392 0.63932 
 
0.0054 
0.4 0.51119 0.50887 0.50764 0.50923 
 
0.0018 
0.3 0.37982 0.38021 0.37623 0.37875 
 
0.0022 
0.2 0.24653 0.24192 0.25914 0.24920 
 
0.0089 






Table A.2  Absorption Data, 400nm for PNP Standard Curve 
[PNP] 




0.5 NA NA NA NA NA 
0.4 2.0137 2.0351 2.0104 2.01973  0.01341 
0.3 1.5049 1.5431 1.4598 1.50260  0.04170 
0.2 0.99768 0.99464 1.0012 0.99784  0.00328 
0.1 0.48963 0.4803 0.49336 0.48776  0.00673 
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Table A.3  Turbidity Data, 910nm for Dry Cell Weight Standard Curve. 
Cell 
Density 




7.5 2.63 2.62 2.62 2.62 0.01 
5 2.25 2.25 2.24 2.25  0.01 
4 2.05 2.06 2.05 2.05  0.01 
3 1.77 1.78 1.78 1.78  0.01 
2.5 1.56 1.57 1.58 1.57  0.01 
2 1.38 1.37 1.38 1.38  0.01 
1.5 1.14 1.15 1.14 1.14  0.01 
1 0.78 0.80 0.77 0.78  0.02 
0.5 0.44 0.43 0.45 0.44  0.01 
0.25 0.21 0.23 0.20 0.21  0.02 




Table A.4  Area Data for Lactose HPLC Standard Curve. 
Concentration 




10.21 1205.72 1208.413 1209.311 1207.815 
 
1.87 
20.42 2353.257 2386.781 2397.956 2379.331 
 
23.26 
30.62 3570.181 3600.313 3610.357 3593.617 
 
20.91 
40.83 4770.027 4783.453 4787.928 4780.47 
 
9.32 
51.04 5997.861 6193.249 6258.378 6149.83 
 
135.58 
61.25 6990.694 7018.685 7028.016 7012.465 
 
19.42 
71.46 7803.779 7803.939 7803.993 7803.904 
 
0.11 
81.67 8409.885 8454.983 8470.016 8444.961 
 
31.29 
91.87 8910.779 8928.339 8928.339 8922.486 
 
10.14 






Table A.5  Area Data for Glucose HPLC Standard Curve. 
Concentration 




5.13 591.181 592.1505 592.4736 591.935 
 
0.67 
10.27 1144.065 1157.854 1162.45 1154.789 
 
9.57 
15.4 1728.168 1740.501 1744.611 1737.76 
 
8.56 
20.53 2308.597 2312.179 4787.928 3136.235 
 
1430.41 
25.67 2917.307 3015.954 2313.373 2748.878 
 
380.37 
30.8 3479.81 3493.242 3497.719 3490.257 
 
9.32 
35.93 4078.241 4078.707 4080.105 4079.018 
 
0.97 
41.06 4607.423 4658.209 4675.137 4646.923 
 
35.24 
46.2 5135.346 5139.369 5151.436 5142.05 
 
8.37 






Table A.6  Area Data for Galactose HPLC Standard Curve. 
Concentration 




5.3 587.5096 588.1352 588.3437 587.9962 
 
0.43 
10.59 1146.574 1160.676 1165.377 1157.542 
 
9.79 
15.89 1736.779 1749.775 1754.107 1746.887 
 
9.02 
21.18 2324.521 2327.419 2328.385 2326.775 
 
2.01 
26.48 2939.6 3038.589 3071.585 3016.591 
 
68.69 
31.78 3505.491 3519.35 3523.969 3516.27 
 
9.62 
37.07 4108.457 4109.237 4111.578 4109.757 
 
1.62 
42.37 4641.737 4687.291 4702.476 4677.168 
 
31.61 
47.66 5158.222 5170.575 5174.237 5167.678 
 
8.39 









STATISTICAL ANALYSIS FOR STANDARD CURVES  
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This appendix contains the statistical analysis of the data used to generate 
standard curves for enzyme activity, dry cell weight determination and sugar analysis by 
HPLC. 
 
B.1. Statistical Analysis of ONP Standard Curve 
The assumptions of constant variance and normality made for ANOVA analysis 
are verified in Figure B.1 and Figure B.2.  The plot of the residuals in Figure B.1shows 
random and independent distribution of errors.  Linearity in Figure B.2 indicates the 


























Squares Mean Squares F-Value P-value 
Regression 1 18.95929753 18.95929753 157408.5 
 Residual 29 0.003492948 0.000120446 





Error Lower 95% Upper 95% 
Absorbance 415 1.281209437 0.003229283 1.274604812 1.287814062 
 
Regression Statistics 
Multiple R 0.999907896 
R Square 0.9998158 





























B.2. Statistical Analysis of PNP Standard Curve 
The assumptions of constant variance and normality made for ANOVA analysis 
are verified in Figure B.3 and Figure B.4.  The plot of the residuals in Figure B.3 shows 
random and independent distribution of errors.  Linearity in Figure B.4 indicates the 






























Squares Mean Squares F-Value P-value 
Regression 1 22.71102 22.71102 48904.85 <<0.00001 
Residual 11 0.005108 0.000464 
  
Total 12 22.71613 





Error Lower 95% Upper 95% 
Absorbance 400 5.023392222 0.022715438 4.973395881 5.073388564 
 
Regression Statistics 
Multiple R 0.999887556 
R Square 0.999775124 





























B.3. Statistical Analysis of Dry Cell Weight Standard Curve 
The assumptions of constant variance and normality made for ANOVA analysis 
are verified in Figure B.3 and Figure B.4.  The plot of the residuals in Figure B.3 shows 
random and independent distribution of errors.  Linearity in Figure B.4 indicates the 






































Squares Mean Squares F-Value P-value 
Model 1 2.5858120 2.58581 2847.803 <.0001 
Residual 11 0.0099880 0.00091   
Total 12 2.5958000    
 
Regression Statistics 
R Square 0.999004 











Squares Mean Squares F-Value P-value 
Model 1 248.19015 248.190 19059.70 <.0001 
Residual 19 0.24741 0.013   
Total 20 248.43756    
 
Regression Statistics 
R Square 0.995026 





B.4. Statistical Analysis of HPLC Standard Curves 
The assumptions of constant variance and normality made for ANOVA analysis 
are verified in Figure B.8, Figure B.9, and Figure B.10.  The plots of the residuals in. 
Figure B.8, Figure B.9 and Figure B.10 show random and independent distribution of 
errors.  Linearity in Figure B.11, Figure B.12, and Figure B.13 indicates the residuals are 














































































































Squares Mean Squares F-Value P-value 
Lactose 
    
 
Model 2 221148151 110574076 6886.007 <.0001 
Residual 27 433560 16057.793 
 
 




    
 
Model 1 82665096 82665096 36767.46 <.0001 
Residual 28 62953 2248.3221 
  
Total 29 82728049 
   
Galactose 
     
Model 1 83899719 83899719 33356.97 <.0001 
Residual 28 70426 2515.2082 
  
Total 29 83970145 




Lactose Glucose Galactose 
R Square 0.998043 0.999239 0.999161 
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